地中海魚類ワクチンの2030年市場予測-ワクチンタイプ、投与経路、魚種、国別の地域分析

地中海魚類ワクチンの市場規模は、2022年の963億2,346万米ドルから2030年には2,090億3,080万米ドルに達すると予想され、2022年から2030年までのCAGRは10.2%と推定されます。

消費者は動物性タンパク質の栄養価の高さを認識しつつあります。また、健康的で持続可能な、薬剤を使用しない、あるいは使用しない高品質の食肉製品に対する需要も急増しています。水産動物に由来する食品（油、キャビア、蛋白質パウダー、食肉など）への需要の高まりは、養殖業者が養殖を保護し、高い収益性を達成するためにワクチン接種を行うことを奨励しています。

定期的な魚の摂取は、健康的な食生活の一部として広く奨励されています。魚類は陸上動物の肉に比べてタンパク質含量が高く、これは陸上動物よりも飼料要求率（FCR）が低いことからも明らかです。さらに、魚類のタンパク質は消化性が高く、必須アミノ酸を豊富に含んでいます。魚介類の摂取は、さまざまな調査を通じて、心臓病、炎症、関節炎のリスク低下と関連しています。魚の健康効果は、主に長鎖オメガ3（n-3）多価不飽和脂肪酸（PUFA）の存在に関連しています。さらに、魚のタンパク質には生物活性ペプチドが豊富に含まれており、人体内での最適な生物学的利用能をサポートする適切な濃度で摂取すれば、多くの健康上の利点が得られます。魚の摂取によるその他の健康効果には、レニン・アンジオテンシン・アルドステロン系（RAAS）の酵素阻害による血圧のコントロール、骨の健康維持、炎症のコントロール（抗酸化ペプチド）、オピオイドペプチドや血小板活性化因子アセチルヒドロラーゼ（PAF-AH）阻害ペプチドの作用による精神的健康の維持などがあります。このように、水生動物由来のタンパク質がもたらす多大な健康効果は、これらの動物の健全な飼育の必要性を示しており、地中海地域における魚類ワクチンの需要を後押ししています。

新規ワクチンの開発：地中海魚類ワクチン市場の機会

細菌、ウイルス、寄生虫によって引き起こされる様々な疾病の発生は、数十年にわたり世界の養殖産業の発展を減速させてきました。人間の健康に害を及ぼすだけでなく、新興の疾病は水産動物にも劇的な影響を与えます。ワクチン接種は、この問題に対処するために採用されている、よく知られた効果的な予防手段です。しかし、従来のワクチンにはいくつかの欠点や限界があり、そのため研究者の関心はキメラマルチピトープワクチンのような新規ワクチンに向けられています。ゲノミクスとイムノプロテオミクスの現在の理解と、現在利用可能なバイオインフォマティクス・ツールに基づき、研究者は現在、免疫細胞によって認識される潜在的な標的エピトープを同定することができます。さらに、全ゲノム配列決定のような技術のコストが下がり続けている魚種は、種特異的ワクチン開発の道を開いています。これらの要因により、地中海魚類ワクチン市場の参入企業は、現在ワクチンが入手できないウイルス性、寄生虫性、細菌性の感染症に対する新しいワクチンの開発に投資するようになると思われます。

さらに、効果的な粘膜ワクチンの開発とその投与プロセスの最適化は、新規ワクチン開発を加速させ、ひいては地中海諸国の養殖事業者が魚類ワクチン接種プロセスを定期化することを促すと予想されます。緊急用（自家）ワクチンの効果的な使用は、新たな疾病課題に対処するのに役立ち、市場参入企業に成長する絶大な機会を創出すると予想されます。

地中海魚類ワクチン市場は、ワクチンタイプ、魚種、投与経路、臨床適応症、国に区分されます。ワクチンタイプに基づき、市場は不活化ワクチン、弱毒化ワクチン、トキソイドワクチン、サブユニットワクチン、結合型ワクチン、組み換えベクターワクチンに二分されます。魚種ベースでは、地中海魚ワクチン市場はターボット、欧州カタクチイワシとシーバス、サケ、地中海スズキ、コモンデンテックスとコモンパンドラ、タイ、ニジマス、スパルス・アウラータ、マス、地中海メカジキとクロマグロ、ハタとカンパチ、その他に二分されます。投与経路の観点から、市場は浸漬ワクチン、注射ワクチン、経口ワクチンに区分されます。また、臨床適応に基づいて、市場は細菌感染とウイルス感染に分類されます。地域別では、フランス、イタリア、スペイン、エジプト、ギリシャ、トルコ、イスラエル、その他の地中海地域が分析対象です。この地域の市場開拓は、水産養殖業の盛況とワクチンの研究開発強化に向けた取り組みの活発化によって推進されています。トルコは、世界最大の海洋魚養殖国の中で第9位にランクされており、欧州諸国の中でも重要な養殖生産量を記録しています。養殖業はトルコの年間水産物総生産量の44.6％を占めています。トルコは、世界で最も急成長している食品生産国です。トルコでは、434の海洋養殖施設が稼動しており、金目鯛や欧州鱸を生産しています。技術の進歩は、過去20年間におけるスズキとタイ生産の急速な成長を促進しました。その結果、同国はスズキとマダイの生産量世界一となり、世界需要の40％を満たすまでになっています。さらに、二酸化炭素排出量の少ない健康的な製品として魚を普及させようとする政府の努力により、国内の魚消費量は増加しています。2021年1月に発表されたトルコ海洋研究財団（TUDAV）の推計によると、同国の魚生産量は2023年までに60万トンに達し、170万米ドル（160万ユーロ）の輸出を占めるといわれています。

一方、養殖や養魚場における様々な病気の管理は、トルコの養殖事業者が直面する大きな課題です。この課題は、定期的な魚のワクチン接種によって対処されています。このように、トルコでは大規模な魚類生産が行われているため、今後数年間で魚類ワクチンの需要が拡大する可能性が高いです。

国連食糧農業機関（FAO）、経済協力開発機構（OECD）、欧州連合（EU）、トルコ海洋研究財団（TUDAV）は、地中海魚類ワクチン市場に関する報告書を作成する際に参照した、いくつかの主要な一次情報源および二次情報源です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

• 主要な洞察

第3章 調査手法

• 調査範囲
• 2次調査
• 1次調査

第4章 地中海魚用ワクチン市場-市場情勢

• 概要
  • 地中海地域のPEST分析
• 地中海沿岸の魚種
• 地中海魚種リスト

第5章 地中海魚類ワクチン市場-地域分析

• 主な市場促進要因
  • 地中海養殖産業発展への政府の取り組み
  • 水生動物由来の食品に対する需要の急増
• 主な市場抑制要因
  • ワクチンの承認に関する厳しい規制政策
• 主な市場機会
  • 新規ワクチンの開発
• 今後の動向
  • 従来型ワクチンからDNAワクチンへのシフト
• 影響分析

第6章 地中海魚類ワクチン市場：地域分析

• 地中海魚類ワクチン市場の収益と予測分析

第7章 地中海魚類ワクチン市場：2030年までの収益と予測：ワクチンタイプ別

• 概要
• 地中海魚類ワクチン市場：2022年および2030年のワクチンタイプ別売上シェア（%）
• 不活化ワクチン
• 生ワクチン
• トキソイドワクチン
• サブユニットワクチン
• 結合型ワクチン
• 組み換えベクターワクチン

第8章 地中海魚類ワクチン市場：2030年までの収益と予測：投与経路別

• 概要
• 地中海魚類ワクチン市場：2022年および2030年の投与経路別売上シェア（%）
• 浸漬ワクチン
• 注射ワクチン
• 経口ワクチン

第9章 地中海魚類ワクチン市場：2030年までの収益と予測：魚種別

• 概要
• 地中海魚類ワクチン市場：2022年および2030年の種目別売上シェア（%）
• ターボット
• 欧州カタクチイワシとシーバス
• サーモン
• 地中海のスズキ
• コモンデンテックスとコモンパンドラ
• 真鯛
• ニジマス
• スパルス・アウラータ
• トラウト
• 地中海メカジキとクロマグロ
• ハタとカンパチ
• その他

第10章 地中海魚類ワクチン市場：2030年までの収益と予測：適応症別

• 概要
• 地中海魚類ワクチン市場：2022年および2030年の適応症別売上シェア（%）
• 細菌感染
• ウイルス感染

第11章 地中海魚類ワクチン市場：2030年までの収益と予測：地域別分析

第12章 COVID-19前後の影響

• COVID-19前後の影響

第13章 地中海魚類ワクチン市場：業界情勢

• 地中海魚類ワクチン市場における成長戦略
• 無機的成長戦略
• 有機的成長戦略

第14章 企業プロファイル

• Zoetis Inc
• Merck & Co Inc
• HIPRA SA
• ICTYODEV SAS
• ACUIPHARMA AQUACULTURE HEALTH SL
• Phibro Animal Health Corp
• Vaxxinova International BV
• Kyoto Biken Laboratories Inc
• Elanco Animal Health Inc
• Ceva SA

第15章 付録

List Of Tables

• Table 1. Mediterranean Fish Vaccine Market Segmentation
• Table 2. Species of Fishes, Disease and Available Vaccine -
• Table 3. Bacterial Pathogens of Fishes -
• Table 4. USDA Approved Bacterial Fish Vaccines -
• Table 5. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
• Table 6. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
• Table 7. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) - Species
• Table 8. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) - Clinical Indication
• Table 9. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) - Bacterial Infection
• Table 10. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) - Viral Infection
• Table 11. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
• Table 12. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
• Table 13. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
• Table 14. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
• Table 15. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
• Table 16. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
• Table 17. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
• Table 18. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
• Table 19. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
• Table 20. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
• Table 21. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
• Table 22. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
• Table 23. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
• Table 24. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
• Table 25. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
• Table 26. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
• Table 27. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
• Table 28. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
• Table 29. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
• Table 30. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
• Table 31. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
• Table 32. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
• Table 33. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
• Table 34. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
• Table 35. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
• Table 36. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
• Table 37. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
• Table 38. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
• Table 39. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
• Table 40. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
• Table 41. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
• Table 42. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
• Table 43. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
• Table 44. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
• Table 45. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
• Table 46. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
• Table 47. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
• Table 48. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
• Table 49. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
• Table 50. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
• Table 51. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
• Table 52. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
• Table 53. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
• Table 54. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
• Table 55. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) -Species
• Table 56. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) -Clinical Indication
• Table 57. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
• Table 58. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
• Table 59. Recent Inorganic Growth Strategies in the Mediterranean Fish Vaccine Market
• Table 60. Recent Organic Growth Strategies in Mediterranean fish vaccine Market
• Table 61. Glossary of Terms

List Of Figures

• Figure 1. Mediterranean Fish Vaccine Market Segmentation, By Region
• Figure 2. Mediterranean Region: PEST Analysis
• Figure 3. Mediterranean Fish Vaccine Market - Key Industry Dynamics
• Figure 4. Impact Analysis of Drivers and Restraints
• Figure 5. Mediterranean Fish Vaccine Market - Revenue Forecast and Analysis - 2020-2030
• Figure 6. Mediterranean Fish Vaccine Market Revenue Share, by Vaccine Type 2022 & 2030 (%)
• Figure 7. Inactivated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 8. Live Attenuated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 9. Toxoid Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 10. Subunit Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 11. Conjugate Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 12. Recombinant Vector Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 13. Mediterranean Fish Vaccine Market Revenue Share, by Route of Administration 2022 & 2030 (%)
• Figure 14. Inactivated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 15. Injection Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 16. Toxoid Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 17. Mediterranean Fish Vaccine Market Revenue Share, by Species 2022 & 2030 (%)
• Figure 18. Turbot: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 19. European Anchovy and Seabass: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 20. Salmon: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 21. Mediterranean Sea Bass: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 22. Common Dentex and Common Pandora: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 23. Sea Bream: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 24. Rainbow Wrasse: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 25. Sparus aurata: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 26. Trout: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 27. Mediterranean Swordfish and Bluefin Tuna: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 28. Grouper and Amberjack: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 29. Others: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 30. Mediterranean Fish Vaccine Market Revenue Share, by Clinical Indication 2022 & 2030 (%)
• Figure 31. Bacterial Infection: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 32. Viral Infection: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 33. Mediterranean Fish Vaccine Market, By Region, 2022 ($Mn)
• Figure 34. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
• Figure 35. Mediterranean Fish Vaccine Market, By Key Countries, 2022 And 2030 (%)
• Figure 36. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
• Figure 37. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
• Figure 38. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
• Figure 39. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
• Figure 40. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
• Figure 41. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
• Figure 42. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
• Figure 43. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
• Figure 44. Pre and Post COVID-19 Impact on Mediterranean Fish Vaccine Market
• Figure 45. Growth Strategies in Mediterranean Fish Vaccine Market

The Mediterranean fish vaccine market size is expected to reach US$ 2,09,030.80 million by 2030 from US$ 96,323.46 million in 2022; it is estimated to record a CAGR of 10.2% from 2022 to 2030.

Consumers are becoming aware of the nutritious value of animal protein. The demand for healthy, sustainable, high-quality meat products with fewer or no drugs is also increasing rapidly. The growing demand for food products derived from aquatic animals (oil, caviar, protein powders, meat, etc.) encourages farmers to undertake vaccinations to safeguard aquaculture and attain high profitability.

Regular fish consumption is widely promoted as a part of a healthy diet. Fishes have a high protein content compared to terrestrial animal meat, which is evident through lower feed conversion rates (FCR) than land animals. Moreover, fish proteins are highly digestible and rich in essential amino acids, unlike animal-sourced proteins that have low essential amino acid content. Fish and shellfish consumption has been associated with a decreased risk of heart disease, inflammation, and arthritis through different research studies. The health benefits of fish are mainly linked to the presence of long-chain omega 3 (n-3) polyunsaturated fatty acids (PUFA). In addition, fish proteins are enriched with bioactive peptides, which offer many health benefits if consumed in appropriate concentrations that support their optimal bioavailability within the human body. Other health benefits of fish consumption include the control of blood pressure through the inhibition of enzymes within the renin-angiotensin-aldosterone system (RAAS); maintenance of bone health; control of inflammation (antioxidant peptides); and maintenance of mental health through the action of opioid peptides and platelet-activating factor acetyl-hydrolase (PAF-AH) inhibitory peptides; and so on. Thus, the tremendous health benefits of aquatic animal-derived proteins indicate the need for healthy breeding of these animals, which propels the demand for fish vaccines in the Mediterranean region.

Development of Novel Vaccines: Opportunity for the Mediterranean Fish Vaccine Market

Various disease outbreaks caused by bacteria, viruses, and parasites have decelerated the progress of the global aquaculture industry for several decades. Besides harming human health, emerging diseases also dramatically affect aquatic animals. Vaccination is a well-known, effective prophylactic measure employed to manage this problem. However, traditional vaccines still have several drawbacks and limitations, which has driven the focus of researchers to novel vaccines such as chimeric multiepitope vaccines. Based on the current understanding of genomics and immunoproteomics, and the presently available bioinformatics tools, researchers can now identify the potential targeted epitopes that are recognized by immune cells. Further, Fish Species with a as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. These factors are likely to encourage the Mediterranean fish vaccine market players to invest in developing new vaccines against viral, parasitic, or bacterial infectious diseases for which vaccines are presently unavailable.

Further, the development of effective mucosal vaccines and optimization of their administration process are expected to accelerate novel vaccine development, in turn, encouraging aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. The effective use of emergency (autogenous) vaccines is anticipated to help handle emerging disease challenges and create immense opportunities for the market players to grow.

The Mediterranean fish vaccine market is segments into vaccine type, species, route of administration, clinical indication, and country. Based on the vaccine type, the market is bifurcated into inactivated vaccine, live-attenuated vaccine, toxoid vaccine, subunit vaccine, conjugate vaccine, and recombinant vector vaccine. Based on species, the Mediterranean fish vaccine market is bifurcated into turbot, European anchovy and seabass, salmon, Mediterranean sea bass, common dentex and common pandora, sea bream, rainbow wrasse, Sparus aurata, trout, Mediterranean swordfish and bluefin tuna, grouper and amberjack, and others. In terms of route of administration, the market is segmented into immersion vaccine, injection vaccine, and oral vaccine. And based on clinical indication, the market is classified as bacterial infection and viral infection. Based on the region, the market is analyzed on the basis of France, Italy, Spain, Egypt, Greece, Turkey, Israel, and the Rest of the Mediterranean. The growth of the market in this region is driven by the flourishing aquaculture industry and increasing initiatives to enhance research and development of vaccines. Turkey ranks ninth among the largest marine fish farming countries in the world, and it records significant aquaculture production among all European countries. Aquaculture accounts for ~44.6% of the total annual seafood production in Turkey. The country claims to have the fastest-growing food production industry in the world. Turkey has 434 operational marine aquaculture facilities, producing gilthead seabream and European seabass. Technological advancements have facilitated the rapid growth in sea bass and sea bream production in the past two decades. Thus, the country has become the world's top producer of sea bream and sea bass, meeting ~40% of the global demand. Moreover, fish consumption in the country is rising due to the government's efforts to promote fish as a healthy product with a low carbon footprint. According to the Turkish Marine Research Foundation (TUDAV) estimates published in January 2021, the country's fish production would reach 600,000 tons by 2023, accounting for exports of US$ 1.7 million (€1.6 million).

On the other hand, managing various diseases in aquaculture and fish farms is a major challenge faced by Turkish aquaculture businesses. This challenge is handled by regular fish vaccination. Thus, the large scale of fish production in Turkey is likely to expand the demand for fish vaccines in the coming years.

The Food and Agriculture Organization of the United Nations (FAO), the Organisation for Economic Co-operation and Development (OECD), European Union, Turkish Marine Research Foundation (TUDAV) are a few key primary and secondary sources referred to while preparing the report on the Mediterranean fish vaccine market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Mediterranean fish vaccine market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global Mediterranean fish vaccine market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global Mediterranean fish vaccine market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Mediterranean Fish Vaccine Market - Market Landscape

• 4.1 Overview
  • 4.1.1 Mediterranean Region PEST Analysis
• 4.2 Mediterranean Fish Species
• 4.3 List of Mediterranean Fish Species

5. Mediterranean Fish Vaccine Market - Regional Analysis

• 5.1 Key Market Drivers:
  • 5.1.1 Government Initiatives to Develop Mediterranean Aquaculture Industry
  • 5.1.2 Surging Demand for Aquatic Animal-Derived Food Products
• 5.2 Key Market Restraints:
  • 5.2.1 Strict Regulatory Policies for Approval of Vaccines
• 5.3 Key Market Opportunities:
  • 5.3.1 Development of Novel Vaccines
• 5.4 Future Trends:
  • 5.4.1 Shift from Conventional Vaccines to DNA Vaccines
• 5.5 Impact Analysis:

6. Mediterranean Fish Vaccine Market - Regional Analysis

• 6.1 Mediterranean Fish Vaccine Market Revenue Forecast and Analysis

7. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type

• 7.1 Overview
• 7.2 Mediterranean Fish Vaccine Market Revenue Share, by Vaccine Type 2022 & 2030 (%)
• 7.3 Inactivated Vaccine
  • 7.3.1 Overview
  • 7.3.2 Inactivated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Live Attenuated Vaccine
  • 7.4.1 Overview
  • 7.4.2 Live Attenuated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 7.5 Toxoid Vaccine
  • 7.5.1 Overview
  • 7.5.2 Toxoid Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 7.6 Subunit Vaccine
  • 7.6.1 Overview
  • 7.6.2 Subunit Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 7.7 Conjugate Vaccine
  • 7.7.1 Overview
  • 7.7.2 Conjugate Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 7.8 Recombinant Vector Vaccine
  • 7.8.1 Overview
  • 7.8.2 Recombinant Vector Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)

8. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration

• 8.1 Overview
• 8.2 Mediterranean Fish Vaccine Market Revenue Share, by Route of Administration 2022 & 2030 (%)
• 8.3 Immersion Vaccine
  • 8.3.1 Overview
  • 8.3.2 Immersion Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Injection Vaccine
  • 8.4.1 Overview
  • 8.4.2 Injection Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 8.5 Oral Vaccine
  • 8.5.1 Overview
  • 8.5.2 Oral Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)

9. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - by Species.

• 9.1 Overview
• 9.2 Mediterranean Fish Vaccine Market Revenue Share, by Species 2022 & 2030 (%)
• 9.3 Turbot
  • 9.3.1 Turbot: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4 European Anchovy and Seabass
  • 9.4.1 European Anchovy and Seabass: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 9.5 Salmon
  • 9.5.1 Salmon: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 9.6 Mediterranean Sea Bass
  • 9.6.1 Mediterranean Sea Bass: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 9.7 Common Dentex and Common Pandora
  • 9.7.1 Common Dentex and Common Pandora: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 9.8 Sea Bream
  • 9.8.1 Sea Bream: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 9.9 Rainbow Wrasse
  • 9.9.1 Rainbow Wrasse: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 9.10 Sparus aurata
  • 9.10.1 Sparus aurata: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 9.11 Trout
  • 9.11.1 Trout: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 9.12 Mediterranean Swordfish and Bluefin Tuna
  • 9.12.1 Mediterranean Swordfish and Bluefin Tuna: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 9.13 Grouper and Amberjack
  • 9.13.1 Grouper and Amberjack: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 9.14 Others
  • 9.14.1 Others: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)

10. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - by Clinical Indication

• 10.1 Overview
• 10.2 Mediterranean Fish Vaccine Market Revenue Share, by Clinical Indication 2022 & 2030 (%)
• 10.3 Bacterial Infection
  • 10.3.1 Overview
  • 10.3.2 Bacterial Infection: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
• 10.4 Viral Infection
  • 10.4.1 Overview
  • 10.4.2 Viral Infection: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)

11. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - Geographic Analysis

• 11.1 Mediterranean Fish Vaccine Market, Revenue and Forecast to 2030
  • 11.1.1 Overview
  • 11.1.2 Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.2.1 Mediterranean Fish Vaccine Market, by Vaccine Type
    • 11.1.2.2 Mediterranean Fish Vaccine Market, by Route of Administration
    • 11.1.2.3 Mediterranean Fish Vaccine Market, by Species
    • 11.1.2.4 Mediterranean Fish Vaccine Market, by Clinical Indication
      • 11.1.2.4.1 Mediterranean Fish Vaccine Market, by Bacterial Infection
      • 11.1.2.4.2 Mediterranean Fish Vaccine Market, by Bacterial Infection
    • 11.1.2.5 Mediterranean Fish Vaccine Market by Country
      • 11.1.2.5.1 France
      • 11.1.2.5.1.1 Overview
      • 11.1.2.5.1.2 France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.5.1.2.1 France: Mediterranean Fish Vaccine Market, by Vaccine Type
      • 11.1.2.5.1.2.2 France: Mediterranean Fish Vaccine Market, by Route of Administration
      • 11.1.2.5.1.2.3 France: Mediterranean Fish Vaccine Market, by Species
      • 11.1.2.5.1.2.4 France: Mediterranean Fish Vaccine Market, by Clinical Indication
      • 11.1.2.5.1.2.4.1 France: Mediterranean Fish Vaccine Market, by Bacterial Infection
      • 11.1.2.5.1.2.4.2 France: Mediterranean Fish Vaccine Market, by Viral Infection
      • 11.1.2.5.2 Italy
      • 11.1.2.5.2.1 Overview
      • 11.1.2.5.2.2 Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.5.2.2.1 Italy: Mediterranean Fish Vaccine Market, by Vaccine Type
      • 11.1.2.5.2.2.2 Italy: Mediterranean Fish Vaccine Market, by Route of Administration
      • 11.1.2.5.2.2.3 Italy: Mediterranean Fish Vaccine Market, by Species
      • 11.1.2.5.2.2.4 Italy: Mediterranean Fish Vaccine Market, by Clinical Indication
      • 11.1.2.5.2.2.4.1 Italy: Mediterranean Fish Vaccine Market, by Bacterial Infection
      • 11.1.2.5.2.2.4.2 Italy: Mediterranean Fish Vaccine Market, by Viral Infection
      • 11.1.2.5.3 Spain
      • 11.1.2.5.3.1 Overview
      • 11.1.2.5.3.2 Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.5.3.2.1 Spain: Mediterranean Fish Vaccine Market, by Vaccine Type
      • 11.1.2.5.3.2.2 Spain: Mediterranean Fish Vaccine Market, by Route of Administration
      • 11.1.2.5.3.2.3 Spain: Mediterranean Fish Vaccine Market, by Species
      • 11.1.2.5.3.2.4 Spain: Mediterranean Fish Vaccine Market, by Clinical Indication
      • 11.1.2.5.3.2.4.1 Spain: Mediterranean Fish Vaccine Market, by Bacterial Infection
      • 11.1.2.5.3.2.4.2 Spain: Mediterranean Fish Vaccine Market, by Viral Infection
      • 11.1.2.5.4 Egypt
      • 11.1.2.5.4.1 Overview
      • 11.1.2.5.4.2 Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.5.4.2.1 Egypt: Mediterranean Fish Vaccine Market, by Vaccine Type
      • 11.1.2.5.4.2.2 Egypt: Mediterranean Fish Vaccine Market, by Route of Administration
      • 11.1.2.5.4.2.3 Egypt: Mediterranean Fish Vaccine Market, by Species
      • 11.1.2.5.4.2.4 Egypt: Mediterranean Fish Vaccine Market, by Clinical Indication
      • 11.1.2.5.4.2.4.1 Egypt: Mediterranean Fish Vaccine Market, by Bacterial Infection
      • 11.1.2.5.4.2.4.2 Egypt: Mediterranean Fish Vaccine Market, by Viral Infection
      • 11.1.2.5.5 Israel
      • 11.1.2.5.5.1 Overview
      • 11.1.2.5.5.2 Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.5.5.2.1 Israel: Mediterranean Fish Vaccine Market, by Vaccine Type
      • 11.1.2.5.5.2.2 Israel: Mediterranean Fish Vaccine Market, by Route of Administration
      • 11.1.2.5.5.2.3 Israel: Mediterranean Fish Vaccine Market, by Species
      • 11.1.2.5.5.2.4 Israel: Mediterranean Fish Vaccine Market, by Clinical Indication
      • 11.1.2.5.5.2.4.1 Israel: Mediterranean Fish Vaccine Market, by Bacterial Infection
      • 11.1.2.5.5.2.4.2 Israel: Mediterranean Fish Vaccine Market, by Viral Infection
      • 11.1.2.5.6 Turkey
      • 11.1.2.5.6.1 Overview
      • 11.1.2.5.6.2 Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.5.6.2.1 Turkey: Mediterranean Fish Vaccine Market, by Vaccine Type
      • 11.1.2.5.6.2.2 Turkey: Mediterranean Fish Vaccine Market, by Route of Administration
      • 11.1.2.5.6.2.3 Turkey: Mediterranean Fish Vaccine Market, by Species
      • 11.1.2.5.6.2.4 Turkey: Mediterranean Fish Vaccine Market, by Clinical Indication
      • 11.1.2.5.6.2.4.1 Turkey: Mediterranean Fish Vaccine Market, by Bacterial Infection
      • 11.1.2.5.6.2.4.2 Turkey: Mediterranean Fish Vaccine Market, by Viral Infection
      • 11.1.2.5.7 Greece
      • 11.1.2.5.7.1 Overview
      • 11.1.2.5.7.2 Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.5.7.2.1 Greece: Mediterranean Fish Vaccine Market, by Vaccine Type
      • 11.1.2.5.7.2.2 Greece: Mediterranean Fish Vaccine Market, by Route of Administration
      • 11.1.2.5.7.2.3 Greece: Mediterranean Fish Vaccine Market, by Species
      • 11.1.2.5.7.2.4 Greece: Mediterranean Fish Vaccine Market, by Clinical Indication
      • 11.1.2.5.7.2.4.1 Greece: Mediterranean Fish Vaccine Market, by Bacterial Infection
      • 11.1.2.5.7.2.4.2 Greece: Mediterranean Fish Vaccine Market, by Viral Infection
      • 11.1.2.5.8 Rest of the Mediterranean
      • 11.1.2.5.8.1 Overview
      • 11.1.2.5.8.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.5.8.2.1 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Vaccine Type
      • 11.1.2.5.8.2.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Route of Administration
      • 11.1.2.5.8.2.3 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Species
      • 11.1.2.5.8.2.4 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Clinical Indication
      • 11.1.2.5.8.2.4.1 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Bacterial Infection
      • 11.1.2.5.8.2.4.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Viral Infection

12. Pre and Post COVID-19 Impact

• 12.1 Pre and Post COVID-19 Impact

13. Mediterranean Fist Vaccine Market - Industry Landscape

• 13.1 Overview
• 13.2 Growth Strategies in Mediterranean Fish Vaccine Market
• 13.3 Inorganic Growth Strategies
  • 13.3.1 Overview
• 13.4 Organic Growth Strategies
  • 13.4.1 Overview

14. Company Profiles

• 14.1 Zoetis Inc
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
• 14.2 Merck & Co Inc
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
• 14.3 HIPRA SA
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
• 14.4 ICTYODEV SAS
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
• 14.5 ACUIPHARMA AQUACULTURE HEALTH SL
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
• 14.6 Phibro Animal Health Corp
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
• 14.7 Vaxxinova International BV
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
• 14.8 Kyoto Biken Laboratories Inc
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments
• 14.9 Elanco Animal Health Inc
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments
• 14.10 Ceva SA
  • 14.10.1 Key Facts
  • 14.10.2 Business Description
  • 14.10.3 Products and Services
  • 14.10.4 Financial Overview
  • 14.10.5 SWOT Analysis
  • 14.10.6 Key Developments

15. Appendix

• 15.1 About The Insight Partners
• 15.2 Glossary of Terms